GENFF (Genflow Biosciences) ROE % Adjusted to Book Value : -17.93% (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Genflow Biosciences ROE % Adjusted to Book Value?

Genflow Biosciences's ROE % for the quarter that ended in Jun. 2024 was -132.67%. Genflow Biosciences's PB Ratio for the quarter that ended in Jun. 2024 was 7.40. Genflow Biosciences's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -17.93%.

Genflow Biosciences ROE % Adjusted to Book Value Historical Data

The historical data trend for Genflow Biosciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences ROE % Adjusted to Book Value Chart

Genflow Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-13.56

Genflow Biosciences Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-	-	-14.49	-20.65	-17.93

Competitive Comparison of Genflow Biosciences's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Genflow Biosciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genflow Biosciences's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genflow Biosciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Genflow Biosciences's ROE % Adjusted to Book Value falls into.

Genflow Biosciences ROE % Adjusted to Book Value Calculation

Genflow Biosciences's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-108.50%	/	8.00
	=	-13.56%

Genflow Biosciences's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-132.67%	/	7.40
	=	-17.93%

Genflow Biosciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Genflow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (OTCPK:GENFF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

GENF:UK

Address

6 Heddon Street, London, GBR, W1B 4BT

Website

https://www.genflowbio.com

Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.